Stimcell Energetics (STME) Cash from Operations (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -16.39% |
| Nov 30, 2025 | 31.44% |
| Aug 31, 2025 | -85.02% |
| May 31, 2025 | -33.70% |
| Feb 28, 2025 | -164.64% |
| Nov 30, 2024 | 27.92% |
| Aug 31, 2024 | 28.98% |
| May 31, 2024 | 14.96% |
| Feb 29, 2024 | -7.41% |
| Nov 30, 2023 | 12.46% |
| Aug 31, 2023 | -57.50% |
| May 31, 2023 | 75.21% |
| Feb 28, 2023 | -52.98% |
| Nov 30, 2022 | 10.69% |
| Aug 31, 2022 | 20.01% |
| May 31, 2022 | -7.76% |
| Feb 28, 2022 | 24.94% |
| Nov 30, 2021 | 22.73% |
| Aug 31, 2021 | -2.30% |
| May 31, 2021 | -49.81% |
| Feb 28, 2021 | 31.50% |
| Nov 30, 2020 | 15.02% |
| Aug 31, 2020 | 26.39% |
| May 31, 2020 | -6.67% |
| Feb 29, 2020 | 21.64% |
| Nov 30, 2019 | -35.35% |
| Aug 31, 2019 | -99.63% |
| May 31, 2019 | 28.19% |
| Feb 28, 2019 | -743.19% |
| Nov 30, 2018 | 63.83% |
| Aug 31, 2018 | -51.43% |
| May 31, 2018 | 64.00% |
| Feb 28, 2018 | 62.00% |
| Nov 30, 2017 | -107.62% |
| Aug 31, 2017 | 44.15% |
| May 31, 2017 | -23.66% |
| Feb 28, 2017 | 44.00% |
| Nov 30, 2016 | -127.13% |
| Aug 31, 2016 | -47.10% |
| May 31, 2013 | 74.73% |
| Feb 28, 2013 | -34.56% |
| Nov 30, 2011 | -296.52% |
| Aug 31, 2011 | 81.47% |